112 related articles for article (PubMed ID: 37200366)
1. Analytical Validation of a Laboratory-Developed Lung Nodule Risk Reclassifier Assay.
Vuong DQ; Yu H; Seger A; Carbonell L; Wu AHB
J Appl Lab Med; 2023 Jul; 8(4):763-772. PubMed ID: 37200366
[TBL] [Abstract][Full Text] [Related]
2. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization.
Trivedi NN; Brown JK; Rubenstein T; Rostykus AD; Fish AL; Yu H; Carbonell L; Juang A; Kamer S; Patel B; Sidhu M; Vuong D; Wang S; Beggs M; Wu AH; Arjomandi M
Biomed Res Rev; 2018 Dec; 2(3):. PubMed ID: 32923944
[TBL] [Abstract][Full Text] [Related]
3. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.
Bigbee WL; Gopalakrishnan V; Weissfeld JL; Wilson DO; Dacic S; Lokshin AE; Siegfried JM
J Thorac Oncol; 2012 Apr; 7(4):698-708. PubMed ID: 22425918
[TBL] [Abstract][Full Text] [Related]
4. Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules.
Ostrin EJ; Bantis LE; Wilson DO; Patel N; Wang R; Kundnani D; Adams-Haduch J; Dennison JB; Fahrmann JF; Chiu HT; Gazdar A; Feng Z; Yuan JM; Hanash SM
J Thorac Oncol; 2021 Feb; 16(2):228-236. PubMed ID: 33137463
[TBL] [Abstract][Full Text] [Related]
5. Analytical validation of a novel multiplex test for detection of advanced adenoma and colorectal cancer in symptomatic patients.
Dillon R; Croner LJ; Bucci J; Kairs SN; You J; Beasley S; Blimline M; Carino RB; Chan VC; Cuevas D; Diggs J; Jennings M; Levy J; Mina G; Yee A; Wilcox B
J Pharm Biomed Anal; 2018 May; 154():85-94. PubMed ID: 29533862
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
Seder CW; Kubasiak JC; Pithadia R; Basu S; Fhied C; Tarhoni I; Davila E; Alnajjar H; Chmielewski GW; Warren WH; Liptay MJ; Borgia JA
Ann Thorac Surg; 2015 Aug; 100(2):429-36. PubMed ID: 26138771
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
9. Vasculature surrounding a nodule: A novel lung cancer biomarker.
Wang X; Leader JK; Wang R; Wilson D; Herman J; Yuan JM; Pu J
Lung Cancer; 2017 Dec; 114():38-43. PubMed ID: 29173763
[TBL] [Abstract][Full Text] [Related]
10. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
11. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
[TBL] [Abstract][Full Text] [Related]
12. Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.
Yang D; Zhang X; Powell CA; Ni J; Wang B; Zhang J; Zhang Y; Wang L; Xu Z; Zhang L; Wu G; Song Y; Tian W; Hu JA; Zhang Y; Hu J; Hong Q; Song Y; Zhou J; Bai C
Cancer; 2018 Jan; 124(2):262-270. PubMed ID: 28940455
[TBL] [Abstract][Full Text] [Related]
13. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
15. Ultralow dose CT for pulmonary nodule detection with chest x-ray equivalent dose - a prospective intra-individual comparative study.
Messerli M; Kluckert T; Knitel M; Wälti S; Desbiolles L; Rengier F; Warschkow R; Bauer RW; Alkadhi H; Leschka S; Wildermuth S
Eur Radiol; 2017 Aug; 27(8):3290-3299. PubMed ID: 28093625
[TBL] [Abstract][Full Text] [Related]
16. Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China.
Li Y; Li M; Zhang Y; Zhou J; Jiang L; Yang C; Li G; Qu W; Li X; Chen Y; Chen Q; Wang W; Wang S; Liang Xing J; Huang H
J Clin Lab Anal; 2021 Jun; 35(6):e23816. PubMed ID: 33982344
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Relationship Between CT Features and Serum Tumor Marker Index in Early-stage Lung Adenocarcinoma.
Xu Y; Sun H; Zhang Z; Song A; Wang W; Lu X
Acad Radiol; 2016 Nov; 23(11):1342-1348. PubMed ID: 27426977
[TBL] [Abstract][Full Text] [Related]
18. Validation of the BRODERS classifier (Benign
Maldonado F; Varghese C; Rajagopalan S; Duan F; Balar AB; Lakhani DA; Antic SL; Massion PP; Johnson TF; Karwoski RA; Robb RA; Bartholmai BJ; Peikert T
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33303552
[TBL] [Abstract][Full Text] [Related]
19. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
20. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
